About Jeff Friedman
Form D filings for Hillhurst Biopharmaceuticals in 2023 list Jeff Friedman as director.
Jeff Friedman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jeff Friedman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Friedman works with at each company, as listed on that company's latest Form D.
Hillhurst Biopharmaceuticals, Inc. · Form D, Sep 26, 2023
AG
Andrew Gomperts
Chief Executive Officer and director
EG
Edward Gomperts
Executive officer and director